
Ask a doctor about a prescription for Betaserc
Betaserc(Betahistine Viatris)
Betahistini dihydrochloridum
Betaserc and Betahistine Viatris are different trade names for the same medicine.
Betaserc contains betahistine. Betaserc is a type of medicine called a "histamine analog".
Betaserc is used to treat Meniere's disease, which is characterized by the following symptoms:
In the symptomatic treatment of dizziness of vestibular origin.
Betaserc works by improving blood flow in the inner ear. This reduces increased pressure.
Before taking Betaserc, the doctor or pharmacist should be consulted if:
Betaserc is not recommended for use in children under 18 years of age.
The doctor or pharmacist should be informed about all medicines currently being taken or recently taken, including those available without a prescription and herbal medicines.
In particular, the doctor or pharmacist should be informed if the patient is taking any of the following medicines:
Betaserc can be taken with or without food. However, Betaserc may cause mild stomach upset (listed in section 4). Taking Betaserc with food may help reduce stomach upset.
It is not known whether Betaserc affects the fetus:
It is not known whether Betaserc passes into breast milk:
It is unlikely that Betaserc will affect the ability to drive or use tools and machines.
However, it should be remembered that the diseases treated with betahistine (Meniere's disease and dizziness) can cause a feeling of spinning and nausea and may affect the ability to drive or use machines.
Betaserc should always be taken as directed by the doctor. In case of doubts, the doctor or pharmacist should be consulted.
Betaserc is available in two strengths: 8 mg and 24 mg. The usual dose is:
If more than one tablet is taken per day, the intake should be spread evenly throughout the day, e.g., one tablet should be taken in the morning and one in the evening.
The tablets should be taken at the same time of day. This will ensure a constant amount of medicine in the body. Taking the medicine at the same time will also help remember to take it.
If more Betaserc is taken than prescribed, nausea, drowsiness, or stomach pain may occur. In case of doubts, the doctor should be consulted.
Betaserc should not be stopped without consulting the doctor, even if an improvement occurs.
In case of any further doubts about the use of the medicine, the doctor or pharmacist should be consulted.
Like all medicines, Betaserc can cause side effects, although not everybody gets them.
After taking this medicine, the following side effects may occur:
If an allergic reaction occurs, Betaserc should be stopped and the doctor or the nearest hospital should be consulted immediately. The symptoms may be:
Frequent(occurring in less than 1 in 10 people):
If any side effects occur, including any possible side effects not listed in the leaflet, the doctor, pharmacist, or nurse should be informed. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Reporting side effects can help gather more information on the safety of the medicine.
Betaserc 24 mg betahistine dihydrochloride is available in the form of round, biconvex, divisible, white to almost white tablets with beveled edges. They have a diameter of 10 mm and are engraved with "289" on one side of the tablet, on both sides of the break line. The break line on the tablet only facilitates breaking for swallowing and does not divide the tablet into equal doses.
Betaserc, 24 mg is available in packs of 20, 60, 100, or 120 tablets, packaged in PVC/PVDC/Al blisters.
For more detailed information, the marketing authorization holder or parallel importer should be contacted.
Viatris GX BV
Terhulpsesteenweg 6A
B-1560 Hoeilaart
Belgium
Mylan Laboratories S.A.S.
Route de Belleville, Lieu-dit Maillard
01400 Châtillon-sur-Chalaronne
France
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Belgian marketing authorization number:BE353245
Date of leaflet approval: 28.09.2023
[Information about the trademark]
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Betaserc – subject to medical assessment and local rules.